Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Cash Flows

v3.21.2
Condensed Consolidated Statement of Cash Flows
 9 Months Ended
Sep. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (6,220,241)
Change in fair value of derivative warrant liabilities (3,037,570)
Financing costs—derivative warrant liabilities 1,111,480
Unrealized gain on investments held in Trust Account (56,354)
Changes in operating assets and liabilities:  
Prepaid expenses (1,111,016)
Accounts payable 914,904
Accrued expenses 5,459,811
Due to related party 968,737
Net cash used in operating activities (1,970,249)
Cash Flows from Investing Activities:  
Cash deposited in Trust Account (977,500,000)
Net cash used in investing activities (977,500,000)
Cash Flows from Financing Activities:  
Repayment of note payable to related party (295,179)
Proceeds received from initial public offering, gross 977,500,000
Proceeds received from private placement 22,250,000
Offering costs paid (19,721,779)
Net cash provided by financing activities 979,733,042
Net increase in cash 262,793
Cash—beginning of the period 0
Cash—end of the period 262,793
Supplemental disclosure of noncash investing and financing activities:  
Offering costs included in accrued expenses 221,134
Offering costs paid by related party under promissory note 295,179
Deferred legal fees 18,182
Deferred underwriting commissions $ 34,212,500